MedTrace Logo

A Novel Method of Lung Isolation Compared With Standard Methods in a Model of Massive Pulmonary Hemorrhage

NCT05001607 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-09-20

No results posted yet for this study

Summary

Dr. Purdy has developed a novel bronchial blocker device that has multiple applications. In this project, a simulation model of massive pulmonary hemorrhage in an adolescent intubating manikin will be used to compare the novel method against 3 published methods of lung isolation.

Conditions

  • Pulmonary Hemorrhage

Interventions

DEVICE

Bronchial Blocker

Trial of four methods of pulmonary blockade; one novel method and three published methods.

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • F Robert Purdy, FRCA · The University of British Columbia

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-16
Primary Completion
2022-07-31
Completion
2022-10-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05001607 on ClinicalTrials.gov